Treatment for Transthyretin Amyloid Cardiomyopathy

Mayo Clinic in Rochester, Rochester, MN
Transthyretin Amyloid Cardiomyopathy+3 More Conditions
All Sexes

Study Summary

This trial is testing a new way to detect a heart condition called transthyretin cardiac amyloidosis (TTR-CA) in people with aortic stenosis.

Eligible Conditions
  • Transthyretin Amyloid Cardiomyopathy
  • Aortic Stenosis
  • Amyloidosis

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase < 1

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline

Prevalence of TTR-CA in patients with moderate and severe aortic stenosis

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

0 Treatment Group

200 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase < 1

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,008 Previous Clinical Trials
3,513,269 Total Patients Enrolled
Omar F Abou Ezzeddine, MDPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 65+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the participant count for this medical study?

"Affirmative. According to the information hosted on, this research endeavour is actively recruiting patients and was initially announced on November 1st 2022 with an edit made 10 days later. The study requires a total of 200 participants from just one medical facility." - Anonymous Online Contributor

Unverified Answer

Are any individuals being sought out to participate in this experiment?

"Yes, indeed. According to, this research study was first published on November 1st 2022 and the information was recently updated on the 10th of that month. The investigators need 200 participants across one medical centre for the trial's completion." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.